August 06, 2025

New Preventive Option Approved for Pediatric Migraine

The FDA has approved Ajovy (fremanezumab-vfrm) for preventive treatment of episodic migraine in pediatric patients aged 6 to 17 years weighing 45 kg or more, expanding its use beyond adults.

Conexiant

August 06, 2025

Not All Problematic Internet Use Is Equal, Expert Argues

Not all screen time is created equal. That’s the message from a recent editorial, which challenges the idea that all forms of problematic internet use led to the same cognitive consequences.

Conexiant

July 29, 2025

Chemo's Impact on Brain Explored

Neuroimaging detects reduced grey matter in multiple brain regions among breast cancer patients after chemotherapy, raising concern for long-term cognitive risks.

Conexiant

July 28, 2025

Race, Sex, and Steps to Cognition

Walking significantly slows cognitive decline in APOE ε4 carriers, with benefits varying by sex and race in 10-year study.

Conexiant

August 05, 2025

Cannabis Use Common Among Adolescents With Chronic Pain, Study Finds

Researchers found that one in four adolescents with chronic pain reported lifetime cannabis use.

Conexiant

August 05, 2025

Whole-Spine Manual Therapy for Cervical Vertigo Studied

Researchers are evaluating the impact of whole-spine manual therapy on vertigo severity, quality of life, and vertebrobasilar artery blood flow in adults with cervical vertigo.

Conexiant

August 04, 2025

Diphenhydramine Risks Outweigh Benefits

Researchers urge physicians to reconsider diphenhydramine use due to safety concerns, high sedation risk, and safer second-generation antihistamine alternatives.

Conexiant

August 04, 2025

Blood Biomarkers Conditionally Recommended for Alzheimer’s Diagnosis 

Clinical practice guideline sets performance thresholds for blood-based biomarkers to assist Alzheimer’s diagnosis in specialty care, with conditional support and emphasis on clinical context.

Conexiant

August 01, 2025

Structured Lifestyle Plan Improves Cognitive Test Scores

Guided lifestyle coaching delivers measurable cognitive improvements over two years, suggesting structure and accountability enhance intervention outcomes in at-risk older adults.

Conexiant